Early Fetal Growth Restriction with or Without Hypertensive Disorders: a Clinical Overview

Reprod Sci. 2024 Mar;31(3):591-602. doi: 10.1007/s43032-023-01330-9. Epub 2023 Sep 8.

Abstract

Early onset fetal growth restriction (FGR) is one of the main adverse pregnancy conditions, often associated with poor neonatal outcomes. Frequently, early onset FGR is associated with early onset hypertensive disorders of pregnancy (HDP), and in particular preeclampsia (PE). However, to date, it is still an open question whether pregnancies complicated by early FGR plus HDP (FGR-HDP) and those complicated by early onset FGR without HDP (normotensive-FGR (n-FGR)) show different prenatal and postnatal outcomes and, consequently, should benefit from different management and long-term follow-up. Recent data support the hypothesis that the presence of PE may have an additional impact on maternal hemodynamic impairment and placental lesions, increasing the risk of poor neonatal outcomes in pregnancy affected by early onset FGR-HDP compared to pregnancy affected by early onset n-FGR. This review aims to elucidate this poor studied topic, comparing the clinical characteristics, perinatal outcomes, and potential long-term sequelae of early onset FGR-HDP and early onset n-FGR.

Keywords: Early onset fetal growth restriction; Hypertensive disorders of pregnancy; Placental insufficiency; Preeclampsia.

Publication types

  • Review

MeSH terms

  • Female
  • Fetal Growth Retardation / etiology
  • Humans
  • Hypertension, Pregnancy-Induced* / diagnosis
  • Hypertension, Pregnancy-Induced* / pathology
  • Infant, Newborn
  • Placenta / pathology
  • Pre-Eclampsia* / pathology
  • Pregnancy
  • Pregnancy Complications* / pathology